Nuveen’s Genprex GNPX Stock Holding History

Nuveen’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9	Closed	-$1.73M	–	3441
2021 Q1	$1.73M	Buy	9 +7	+350%	+$1.54M	﹤0.01%	2685
2020 Q4	$406K	Hold	2	–	–	﹤0.01%	3087
2020 Q3	$321K	Sell	2 -1	-33%	-$158K	﹤0.01%	3070
2020 Q2	$426K	Buy	+3	New	+$367K	﹤0.01%	2961

Other funds holding GNPX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Nuveen's GNPX Position: Q2 2021 in Review

Nuveen sold out of Genprex (GNPX) in Q2 2021, closing a stake of 9 shares — an estimated $1.73M sold.

Nuveen first reported a position in GNPX in Q2 2020 and held it in 4 quarters. The position peaked at $1.73M in Q1 2021. 32 funds tracked by Wall St. Rank hold GNPX as of Q2 2021.

Nuveen reported no remaining Genprex position as of Q2 2021 after selling out during the quarter.
Nuveen sold 9 Genprex shares in Q2 2021, an estimated $1.73M.
Nuveen first reported a position in Genprex in Q2 2020 and held it in 4 quarters.
Nuveen's Genprex position peaked at $1.73M in Q1 2021.
32 funds tracked by Wall St. Rank held Genprex as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.